📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
TNPETRO Revises Project Costs to ₹602 Cr and Announces New ₹90 Cr Downstream Units
Tamilnadu PetroProducts Limited (TNPETRO) has announced a significant revision in its ongoing project costs and a new expansion plan. The cost for the LAB plant expansion has been revised from ₹310 crore to ₹365 crore, while the HCD plant expansion cost increased from ₹214 crore to ₹237 crore due to forex fluctuations and cost escalations. Additionally, the board approved ₹90 crore for setting up two new downstream units in the HCD plant, expected to be completed within 18 months. The total capital commitment for these projects now exceeds ₹690 crore, funded via internal accruals and debt.
Key Highlights
LAB plant expansion cost increased by 17.7% from ₹310 crore to ₹365 crore.
HCD plant expansion cost revised from ₹214 crore to ₹237 crore citing forex and time-related escalations.
New ₹90 crore investment approved for two downstream units in the HCD plant with an 18-month execution timeline.
Total project outlay across these updates stands at approximately ₹692 crore.
Funding strategy involves a mix of internal accruals and borrowings based on future business conditions.
💼 Action for Investors
Investors should monitor the impact of the ₹78 crore cost overrun on the company's margins and debt levels. While the expansion into downstream units is positive for long-term value addition, the delay and cost escalation in existing projects warrant a cautious approach.
SEPC Credit Rating Downgraded to 'D' (Default) by CRISIL and Infomerics
SEPC Limited has experienced a severe credit rating downgrade from both CRISIL Ratings and Infomerics Valuation and Rating. Both agencies have moved the company's long-term and short-term bank facilities to a 'D' (Default) rating. Previously, CRISIL had rated the long-term facilities at 'BB+/Negative' and short-term at 'A4+'. This downgrade to 'D' signifies that the company has defaulted on its debt obligations or is expected to do so imminently, reflecting a critical liquidity crisis.
Key Highlights
CRISIL downgraded Long Term Bank Facilities from 'BB+/Negative' to 'D'
CRISIL downgraded Short Term Bank Facilities from 'A4+' to 'D'
Infomerics downgraded Long Term Bank Facilities from 'BB+/Negative' to 'IVR D'
Infomerics downgraded Short Term Bank Facilities from 'IVR 4+' to 'IVR D'
💼 Action for Investors
Investors should exercise extreme caution as a 'D' rating indicates a default on financial obligations, which typically leads to significant stock price volatility and potential insolvency risks. It is advisable to evaluate the company's debt restructuring plans and liquidity position before maintaining any exposure.
ICRA Places Fino Payments Bank Ratings on Watch Following MD & CEO Arrest
ICRA has placed Fino Payments Bank's ratings of [ICRA]BBB+ and [ICRA]A2+ on 'Watch with Developing Implications'. This rating action follows the arrest of the bank's Managing Director & CEO, Mr. Rishi Gupta, which was initially disclosed on February 27, 2026. The watch applies to fund-based overdraft facilities totaling Rs. 294.54 crore. While the ratings remain unchanged for now, the developing implications status reflects uncertainty regarding management stability and potential operational impacts.
Key Highlights
ICRA places [ICRA]BBB+ and [ICRA]A2+ ratings on 'Watch with Developing Implications'
The rating action affects a total fund-based overdraft limit of Rs. 294.54 crore
Triggered by the arrest of MD & CEO Mr. Rishi Gupta as reported in late February 2026
Major bank limits include Rs. 80 crore with ICICI Bank and Rs. 73.44 crore with State Bank of India
Mr. Ketan Merchant has been identified as the Interim CEO to oversee current operations
💼 Action for Investors
Investors should exercise caution and closely monitor further updates regarding the legal proceedings of the former CEO and the bank's management transition. The 'Watch' status indicates a potential for future rating volatility which could impact the bank's cost of funds and institutional reputation.
iValue Infosolutions Outlines AI Strategy; India AI Mission Deploys 38,000+ GPUs
iValue Infosolutions held a strategic business update call to discuss the impact of AI on its IT infrastructure and cybersecurity operations. Management highlighted the India AI Mission's deployment of over 38,000 GPUs and the registration of 2,300+ startups as significant growth catalysts for the ecosystem. The company is positioning itself as an integrator to manage the 400 million terabytes of data generated daily across sectors like BFSI and Healthcare. iValue aims to address the complexities of 'Shadow AI' and governance as enterprises transition to Generative AI models.
Key Highlights
India AI Mission has deployed 38,000+ GPUs to support sovereign compute and data center expansion.
Over 2,300 startups are registered under the India AI Mission, driving demand for AI-integrated solutions.
Global data generation has reached 400 million terabytes daily, increasing the need for AI-driven analysis.
BFSI sector identified as high-impact with banks running 700-800 applications that require AI for fraud detection.
Company focusing on AI governance to mitigate risks from 'Shadow AI' where employees use ungoverned public AI tools.
💼 Action for Investors
Investors should view this as a positive long-term strategic positioning in the high-growth AI infrastructure and cybersecurity space. Monitor the company's ability to secure contracts within the expanding 38,000+ GPU data center ecosystem in India.
Capri Global Capital Board Approves ₹2,000 Crore Fundraise via Public Issue of NCDs
Capri Global Capital Limited (CGCL) has received board approval to raise up to ₹2,000 crore through the public issuance of Secured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs). The fundraise will be conducted in one or more tranches with a face value of ₹1,000 per debenture. While the total shelf limit is set, specific terms such as coupon rates, tenure, and security details are yet to be finalized. This capital infusion is intended to support the company's lending operations and growth objectives.
Key Highlights
Board approved a total fundraise of up to ₹2,000 crore through NCDs
Proposed issuance of up to 2,00,00,000 NCDs with a face value of ₹1,000 each
The securities will be secured, rated, and listed on the BSE Limited
Fundraising will occur in one or more tranches with terms to be finalized in the future
💼 Action for Investors
Investors should monitor the upcoming announcements regarding the specific coupon rates and credit ratings of these NCDs to assess the company's cost of capital. A successful fundraise will provide necessary liquidity for CGCL to expand its loan book in the MSME and housing finance sectors.
Capri Global Capital Board Approves ₹2,000 Crore Fundraise via Public Issue of NCDs
Capri Global Capital Limited (CGCL) has received board approval to raise up to ₹2,000 crore through the public issuance of Secured, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs). The issuance will comprise up to 2 crore NCDs with a face value of ₹1,000 each, to be issued in one or more tranches. While specific terms such as coupon rates and tenure are yet to be finalized, the capital is intended to bolster the company's lending capacity. This move reflects the company's strategy to diversify its funding sources and support long-term growth.
Key Highlights
Approved fundraise of up to ₹2,000 crore through a public issue of NCDs
Issuance of up to 2,00,00,000 NCDs with a face value of ₹1,000 each
Securities will be Secured, Rated, and listed on the BSE Limited
Fundraising to be executed in one or more tranches based on market conditions
Specific terms including coupon rate and tenure to be finalized in subsequent meetings
💼 Action for Investors
Investors should monitor the credit rating and coupon rates once finalized to assess the company's cost of borrowing and financial health. The fundraise is a positive signal for growth, but the impact on margins will depend on the final interest rates offered.
Imagicaaworld to Launch India's First 10,000 Sq. Ft. Hello Park in Hyderabad
Imagicaaworld Entertainment's subsidiary, Imagicaa Next, has signed a Letter of Intent to launch India's first 'Hello Park' at Lake Shore Y Junction Mall in Hyderabad. The 10,000 sq. ft. indoor facility is designed for children aged 3-12 and is expected to open before the 2026 year-end festive season. This move marks the company's entry into the low-capex indoor entertainment segment, aiming to diversify its portfolio beyond large-scale outdoor theme parks. The location is strategic, situated in a 1.6 million sq. ft. mall with high footfall in a dense residential catchment.
Key Highlights
Launching India's first Hello Park in Hyderabad, spanning approximately 10,000 square feet.
Strategically located in Lake Shore Y Junction Mall, a 1.6 million sq. ft. retail hub opened in Dec 2025.
Target opening set before the 2026 year-end festive season to capture peak holiday demand.
New low-capex format focused on children aged 3-12, blending physical play with digital interactivity.
Expansion strategy includes rolling out multiple parks across key urban markets in India.
💼 Action for Investors
Investors should monitor the successful launch and footfall of this first indoor park as it represents a new, scalable, low-capex growth lever for the company. This diversification could lead to more stable year-round revenue compared to seasonal outdoor parks.
Dr. Reddy's Announces Senior Management Reshuffle; M V Ramana Named CEO of Global Generics
Dr. Reddy's Laboratories has announced a significant restructuring of its senior leadership team effective April 1, 2026. Mr. M S Madhu Sundar, who has 28 years of industrial experience, has been elevated to Global Head of Quality and Pharmacovigilance. Key executive roles have been redefined, including M V Ramana as CEO of Global Generics and Sanjay Sharma as Chief Operating Officer. This reshuffle appears to be a strategic move to streamline global manufacturing, quality, and product development operations.
Key Highlights
Mr. M S Madhu Sundar elevated to Global Head of Quality and PV, leveraging 28 years of industry expertise.
Mr. M V Ramana appointed as CEO of Global Generics, a core business segment for the company.
Mr. Sanjay Sharma designated as Chief Operating Officer (COO) effective April 1, 2026.
New leadership appointments made for Integrated Product Development (IPDO) and Consumer Health Organization.
💼 Action for Investors
Investors should monitor the transition of these leaders into their new roles, particularly focusing on the execution of the Global Generics strategy. No immediate portfolio changes are recommended as these are internal elevations and planned role transitions.
Sical Logistics Completes Rights Issue Subscription Period; Closed on March 10, 2026
Sical Logistics Limited has successfully concluded the subscription period for its rights issue on March 10, 2026. The issue, involving equity shares with a face value of Rs. 10, was open for subscription starting February 26, 2026. This capital-raising initiative was previously approved by the Board in meetings held throughout January and February 2026. The company will now move toward the allotment and listing of the new equity shares.
Key Highlights
Rights issue subscription period closed on March 10, 2026, at 5:00 p.m. IST.
The issue was open for a total of 13 days, having commenced on February 26, 2026.
Equity shares offered in the rights issue carry a face value of Rs. 10 per share.
The fundraise follows board approvals dated January 23, February 12, and February 13, 2026.
💼 Action for Investors
Investors should monitor the basis of allotment and the subsequent listing of the new shares on the exchanges. Evaluate the impact of the capital infusion on the company's leverage and future expansion plans.
Metropolis Healthcare Sets March 20 as Record Date for 3:1 Bonus Issue
Metropolis Healthcare Limited has finalized March 20, 2026, as the record date for its 3:1 bonus share issuance. Shareholders holding the stock on this date will be eligible to receive three additional fully paid-up equity shares for every one share they currently own. This corporate action follows the board's recommendation in February 2026 and recent shareholder approval. The deemed date for the allotment of these new shares is scheduled for March 23, 2026.
Key Highlights
Bonus issue ratio confirmed at 3:1 (3 new shares for every 1 existing share)
Record date for eligibility fixed as Friday, March 20, 2026
Deemed date of allotment for bonus shares is Monday, March 23, 2026
Face value of shares remains unchanged at INR 2 per equity share
💼 Action for Investors
Existing shareholders should hold their positions through the record date to qualify for the bonus; note that the share price will adjust downward proportionally on the ex-date. Potential investors should monitor the ex-date to understand the impact on liquidity and price per share.
iValue Infosolutions Outlines AI Growth Strategy and India AI Mission Opportunities
iValue Infosolutions held a business update call to discuss the transformative impact of AI on its service offerings in cybersecurity and IT infrastructure. The management highlighted the India AI Mission, which has already deployed over 38,000 GPUs and registered 2,300+ startups, as a major tailwind for the industry. With India generating 400 million terabytes of data daily, the company is positioning itself as a key integrator for enterprises in BFSI, Healthcare, and Retail. The strategy focuses on addressing AI complexities, including governance of 'Shadow AI' and sovereign compute requirements.
Key Highlights
India AI Mission has deployed 38,000+ GPUs with a dedicated budget to support over 2,300 registered startups.
India generates approximately 400 million terabytes of data daily, necessitating advanced AI-driven churn and analysis.
Identified BFSI as a high-impact sector where typical banks manage 700 to 800 applications generating vast data pools.
Focusing on 'Shadow AI' governance to help organizations protect private data from being uploaded to public Generative AI tools.
Positioning as an integrated solution provider for the 'Sovereign Compute' shift, ensuring data remains within Indian data centers.
💼 Action for Investors
Investors should view this as a positive strategic alignment with India's digital infrastructure goals, though execution in the competitive AI integration space remains key. Monitor future earnings for specific revenue contributions from AI-led infrastructure and security projects.
Fractal Q3 FY26 Revenue Grows 21% YoY to INR 8,544 Million; Quarterly PAT Crosses INR 1 Billion
Fractal Analytics reported a strong Q3 FY26 with revenue from operations reaching INR 8,544 million, a 21% YoY increase. The company achieved a significant milestone as quarterly Profit After Tax (PAT) crossed the INR 1 billion mark for the first time. Growth was primarily driven by the Healthcare and Life Sciences vertical, which surged 78% YoY, while the core CPG and Retail segment grew by 14%. The company maintained a robust Net Revenue Retention (NRR) of 114% and expanded its 'Must-Win Clients' base to 127.
Key Highlights
Revenue from operations grew 21% YoY to INR 8,544 million, with constant currency growth at 14%.
Healthcare and Life Sciences vertical delivered exceptional 78% YoY growth, while BFSI grew 26%.
Quarterly Profit After Tax (PAT) surpassed the INR 1 billion milestone with a gross margin of 47.2%.
Net Revenue Retention (NRR) remained strong at 114%, with 83% of revenue coming from 127 Must-Win Clients.
Secured preferred supplier status with two 'Magnificent Seven' clients and launched Vaidya 2.0 healthcare AI model.
💼 Action for Investors
Investors should focus on the company's successful diversification into Healthcare and its ability to maintain high margins while scaling. The crossing of the INR 1 billion PAT milestone and preferred status with global tech giants are strong indicators of long-term competitive advantage in the AI services space.
Whirlpool of India Completes 100% Acquisition of Elica India with 3.18% Stake Purchase
Whirlpool of India Limited has successfully completed the acquisition of an additional 3.18% stake in Elica PB Whirlpool Kitchen Appliances Private Limited. This transaction involved the purchase of 154,105 equity shares, following an initial intimation made in February 2026. With this final step, Elica India has now become a 100% wholly-owned subsidiary of Whirlpool of India. This consolidation is expected to streamline operations and strengthen Whirlpool's presence in the premium kitchen appliances segment.
Key Highlights
Acquired 154,105 additional equity shares in Elica PB Whirlpool Kitchen Appliances Private Limited
The additional stake represents 3.18% of the total issued and paid-up share capital
Whirlpool of India now holds 100% ownership of Elica India, making it a wholly-owned subsidiary
The acquisition was finalized on March 10, 2026, concluding the process initiated in February 2026
💼 Action for Investors
Investors should view this as a positive strategic move to consolidate a key business segment. Monitor the upcoming quarterly results to see how full ownership impacts consolidated margins and revenue growth.
Choice International to Acquire Remaining 50% Stake in Choice Insurance for ₹62.5 Crore
Choice International Limited has received IRDAI approval to acquire the remaining 50% equity stake in its subsidiary, Choice Insurance Broking India Private Limited. The company is purchasing 6,60,000 shares at ₹947 per share for a total cash consideration of ₹62.50 crore. Following this transaction, Choice Insurance will become a wholly-owned subsidiary of the company. The target entity has shown significant growth, with its turnover rising from ₹6.08 crore in FY23 to ₹88.59 crore in FY25.
Key Highlights
Acquisition of 6,60,000 equity shares at ₹947 per share, totaling ₹62.50 crore
Choice Insurance Broking becomes a 100% Wholly Owned Subsidiary post-acquisition
Target entity reported a turnover of ₹88.59 crore and net worth of ₹19.66 crore for FY25
Insurance broking revenue grew exponentially from ₹6.08 crore in FY23 to ₹88.59 crore in FY25
Necessary regulatory approval from IRDAI has been successfully obtained
💼 Action for Investors
This consolidation of a high-growth insurance vertical is a positive strategic move. Investors should monitor the impact on consolidated margins as the company gains full control over the subsidiary's cash flows.
Protean eGov Receives Tax Demand Order of ₹22.63 Crore Under MVAT and CST Acts
Protean eGov Technologies has received an Order-in-Appeal from the Deputy Commissioner of Sales Tax (Appeals), Mumbai, confirming a tax demand for the financial year 2015-16. The total demand amounts to approximately ₹22.63 crore, primarily related to the nature and scope of PAN services under the Maharashtra Value Added Tax (MVAT) Act. This follows a previous remand of the matter by the Maharashtra Sales Tax Tribunal in 2022. The company maintains that the demand is not maintainable and is evaluating legal options to file a further appeal.
Key Highlights
Total MVAT demand of ₹22,60,25,562 including interest of ₹4.94 crore and penalty of ₹3.53 crore
Additional CST demand of ₹3,20,096 including interest and penalties for the same period
The dispute pertains to PAN services rendered by the company during the 2015-16 period
Order-in-Appeal was issued against an original assessment order dated April 5, 2017
Company is exploring further legal appeals and does not envisage immediate material financial impact
💼 Action for Investors
Investors should monitor the outcome of the company's planned appeal as a final unfavorable ruling would result in a ₹22.6 crore liability. While the company is contesting the demand, this remains a contingent liability that could impact future cash flows.
IndiGo CEO Pieter Elbers Resigns; MD Rahul Bhatia Takes Interim Charge
InterGlobe Aviation (IndiGo) has announced the immediate resignation of its CEO, Pieter Elbers, effective March 10, 2026. Managing Director and founder Rahul Bhatia will assume interim management of the airline's affairs until a permanent successor is named. This leadership change occurs as IndiGo maintains a dominant market position with a fleet of 400+ aircraft and 124 million passengers served in CY25. The company expects to announce a new leader in short order to ensure continuity in its operational and strategic goals.
Key Highlights
CEO Pieter Elbers resigned effective close of business on March 10, 2026
Managing Director Rahul Bhatia to assume interim management responsibilities immediately
IndiGo currently operates a fleet of 400+ aircraft with over 2,200 daily flights
The airline served 124 million customers in CY25 across 135+ global destinations
Board expects to announce a new permanent leadership appointment in short order
💼 Action for Investors
Investors should monitor the timeline for a permanent CEO appointment and watch for any potential shifts in the airline's aggressive expansion strategy. While the founder's interim role provides stability, the sudden leadership transition may lead to short-term stock price volatility.
JSW Infrastructure Starts Interim Operations at Kudathini Rail Siding in Karnataka
JSW Infrastructure's wholly-owned subsidiary, JSW Port Logistics Private Limited, has officially commenced interim operations at its brownfield Rail Siding located in Kudathini, Ballari, Karnataka. This operational milestone follows the acquisition of the asset previously announced on September 11, 2025. The move is part of the company's strategy to enhance its last-mile connectivity and logistics capabilities. Investors should note that the transition from acquisition to operation is a key driver for future revenue growth in the logistics segment.
Key Highlights
Commencement of interim operations at the Kudathini Rail Siding in Ballari, Karnataka.
Asset managed by JSW Port Logistics Private Limited, a 100% subsidiary of JSW Infrastructure.
Follow-up to the brownfield acquisition announced on September 11, 2025.
Strategic expansion into rail-linked logistics to improve port-to-hinterland connectivity.
💼 Action for Investors
This is a positive development indicating efficient execution of post-acquisition integration. Investors should maintain a positive outlook as the company operationalizes its acquired assets to drive revenue growth.
Morepen Labs Secures ₹30 Crore Unsecured Working Capital Loan from KEB Hana Bank
Morepen Laboratories has entered into an agreement with KEB Hana Bank to avail an unsecured working capital term loan of ₹30 crore. The loan carries a competitive interest rate of 7.30% per annum (Repo + 2.05%) and has a tenure of 3 years, including a 6-month moratorium. This facility is backed by a personal guarantee from the Promoter and CMD, Mr. Sushil Suri. The company's existing debt, excluding this new facility, stands at ₹164.62 crore.
Key Highlights
Execution of a ₹30 crore unsecured working capital term loan facility with KEB Hana Bank.
Interest rate set at prevailing repo rate + 2.05%, currently effective at 7.30% per annum.
Loan tenure of 3 years with a 6-month moratorium and 5 half-yearly equal installments.
Personal guarantee provided by Promoter, Chairman & Managing Director Mr. Sushil Suri.
Total outstanding debt of the company (excluding this loan) is ₹164.62 crore as of March 10, 2026.
💼 Action for Investors
Investors should monitor the company's debt-to-equity ratio and ensure that the additional working capital effectively supports revenue growth. The promoter's personal guarantee is a positive sign of internal confidence in the company's repayment capacity.
Aster DM Appoints Founder Dr. Azad Moopen as Executive Director until May 2028
The Board of Aster DM Healthcare has approved the appointment of its founder, Dr. Azad Moopen, as an Executive Director effective from April 15, 2026, through May 28, 2028. This role is a redesignation from his current position as Managing Director, though he will continue to serve as the Chairman of the Company. The appointment is subject to shareholder approval via a postal ballot. This move is intended to ensure leadership continuity and leverage Dr. Moopen's decades of institutional knowledge and operational expertise.
Key Highlights
Dr. Azad Moopen appointed as Executive Director for a term from April 15, 2026, to May 28, 2028
Redesignated from Managing Director while retaining his position as Chairman of the Board
Appointment requires final approval from shareholders through a postal ballot process
Dr. Moopen has been associated with the company since its establishment in 1987
Leadership team includes family members Ms. Alisha Moopen (Deputy MD) and Dr. Zeba Azad Moopen (Non-Executive Director)
💼 Action for Investors
Investors should view this as a positive step for leadership stability and continuity of the company's strategic vision. No immediate action is required as the founder remains at the helm of the organization.
Central Bank of India Renews Co-Lending Tie-up with Capri Global Capital (AUM ₹23,916 Cr)
Central Bank of India has renewed its co-lending partnership with Capri Global Capital Ltd to offer secured Loan Against Property (LAP) and Gold Loans. Capri Global brings a substantial network of 1,331 branches across 19 states and an AUM of ₹23,916 crore as of December 2025. The partnership aims to leverage Capri's origination and servicing capabilities to expand the bank's credit portfolio at competitive rates. This arrangement complies with the revised RBI Co-Lending Arrangement guidelines issued in November 2025.
Key Highlights
Renewal of co-lending partnership with Capri Global Capital Ltd for Secured LAP and Gold Loans
Capri Global Capital manages a significant AUM of ₹23,916 crore as of December 31, 2025
Access to an extensive distribution network of 1,331 branches across 19 States and Union Territories
Adherence to revised RBI Co-Lending Arrangement (CLA) guidelines dated November 28, 2025
Joint credit processing and blended interest rates designed to enhance customer outreach and portfolio growth
💼 Action for Investors
Investors should monitor the growth in the bank's retail and MSME books through such partnerships, as they offer a low-cost expansion route. The focus on secured assets like Gold Loans and LAP is a positive sign for maintaining asset quality.